Vimarsana
Biggest News Aggregation in the World

Google Deepvariant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Google Deepvariant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Google Deepvariant Today - Breaking & Trending Today

Gene editing is now a medical reality - Vimarsana News

Gene editing is now a medical reality

The FDA approved a gene editing therapy to treat sickle cell patients.

Source: yahoo.com
PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis - Vimarsana News

PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis

PacBio WGS Variant Pipeline Will Bring Standardization to PacBio HiFi Data Analysis MENLO PARK, Calif., Oct. 11, 2023 /PRNewswire/ -- PacBio , a leading developer of high-quality, highly accurate...

PacBio Announces Complete Computational Workflow for Human Genome - Vimarsana News

PacBio Announces Complete Computational Workflow for Human Genome

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of PacBio WGS Variant Pipeline – a complete, standardized computational method for HiFi whole genome sequencing (WGS) data analysis.

Google Cloud unveils AI suites for faster and cheaper drug development - Vimarsana News

Google Cloud unveils AI suites for faster and cheaper drug development

A large number of pharmaceutical companies are now taking the help of AI to develop drugs. Google Cloud has unveiled two new suites of AI tools that aim to help the pharmaceutical industry accelerate drug discovery and make it cheaper.

Google Cloud puts focus on precision medicine and life sciences with new AI tools - Vimarsana News

Google Cloud puts focus on precision medicine and life sciences with new AI tools

Improved drug discovery and innovations in personalized treatments are among the goals for the new Target and Lead Identification Suite and Multiomics Suite.